6 results about "Lipid matrix" patented technology

A cosmetic system for sustained dermal delivery, characterized in that it comprises: • a first component (10) in a solid state, comprising an anhydrous lipid-based matrix and at least one bioactive agent, in particular a polynucleotide (PDRN), provided as surface-treated or encapsulated particles; • a second component (20) in a liquid state, comprising an aqueous activator mist (21) containing a non-ionic surfactant system and at least one penetration accelerator;• wherein the first component (10) is configured such that, upon contact with the activator mist (21), it undergoes an in-situ phase inversion from a solid lipid state, appearing as a solid track (11), to a resulting liquid serum state (12), characterized by a reduction in interfacial tension, which generates a capillary wicking effect for dermal delivery into skin microstructures (31) without the use of fibrous carrier substrates.

Process for coloring a lipid matrix blue from Ravenala madagascariensis arils. The invention relates mainly to a process for coloring a lipid matrix blue, which is essentially characterized in that it comprises at least the steps of: supplying or preparing a lipid matrix in liquid form; supplying or preparing seed arils of the plant species Ravenala madagascariensis; extracting the blue fat from the arils into the lipid matrix in liquid form, heated to a temperature between 40 and 60°C; and obtaining a blue-colored lipid composition. Depending on the nature of the lipid matrix used, the resulting lipid composition can be used in the cosmetic or food industries.

This invention belongs to the field of transdermal drug delivery nanocarrier technology, specifically relating to a nanoliposome using coconut oil as the lipid matrix and a specific Li medicinal herb composition (Alpinia oxyphylla + Artemisia argyi + Patchouli) as a natural penetration enhancer, and its preparation method. This product is a derivative of the core patent "A Natural Transdermal Permeation Enhancer Composition Based on Hainan Li Medicinal Herbs and Its Application" (patent application number: 2026106311990), used to significantly improve the transdermal efficiency and skin retention of the penetration enhancer composition, suitable for topical drugs and functional skin care products, realizing the industrialization extension of the core patent technology.

A composition containing a plurality of particles containing a core having a lipid matrix including an active ingredient dispersed therein is disclosed. The active ingredient can include a fat-soluble active ingredient. The particles can be contained in a capsule. Also provided are methods for producing a pharmaceutical composition containing a plurality of particles containing a core having a lipid matrix including an active ingredient dispersed therein.

This invention is a "Bio-Active Therapeutic Skin Cream"; it is a scientifically formulated advanced Bio-Active Therapeutic Matrix, which is primarily composed of active ingredients derived from natural extracts; Organic Cold-Extracted (55599) Oils; Unrefined Shea Butter, Wax (Vitellaria paradoxa) (Cera alba) and Triple-Rendered Beef Tallow. The main benefits of this invention are: - Repairing the skin's natural moisture barrier function; - Treating severe skin dryness (Xerosis): - Itching (Pruritus): For the treatment and prevention of eczema (Atopic / Contact Dermatitis) and seborrheic dermatitis (Cradle Cap / Seborrheic Dermatitis) in children and adults without any side effects in all age groups. The product is an advanced industrial product and manufacturing process that is prepared by cold pressing and a slow infusion method (Cold Extended Infusion) for at least 2 weeks in a low-temperature controlled system to ensure that the active phytochemicals of the plant are fully integrated into the lipid matrix without being broken down or burned.

The invention is related to a process for separating lipids of differing degrees of unsaturation, comprising forming crystals in a lipid blend and separating liquid and solid fractions by a separation step The lipid blend is first cooled to a temperature below the crystallisation temperature of at least one higher-melting component to obtain a rigid solid lipid matrix, and the rigid solid lipid matrix is then subjected to centrifugal forces of at least 500g (RCF) to expel a liquid fraction enriched in lower-melting, more unsaturated lipids, the separation being carried out in the substantial absence of added solvent.